Evidence map›Paper›PMID 41974738›Full record

ArticleNPJ biofilms and microbiomes2026

Staphylococcus aureus biofilm extracellular DNA neutralizes the antimicrobial activity of histone H3.

Pranav S J B Rana, Jack R Foley, Mohini Bhattacharya, Erin S Gloag, Daniel J Wozniak

Abstract read
In one paragraph

Article in NPJ biofilms and microbiomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Biofilm-associated genes inFrontiers in microbiology · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pranav S J B RanaDepartment of Microbiology, The Ohio State University, Columbus, OH, USA.
Jack R FoleyDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USA.
Mohini BhattacharyaDepartment of Microbiology, The Ohio State University, Columbus, OH, USA.
Erin S GloagDepartment of Biomedical Sciences and Pathobiology, Virginia Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, USA.
Daniel J WozniakDepartment of Microbiology, The Ohio State University, Columbus, OH, USA. Daniel.Wozniak@osumc.edu.

Funding

Cooperation and antagonism in polymicrobial infectionR01AI186380 · NIAID · OHIO STATE UNIVERSITY · PI MATTHEW R. PARSEK, Daniel J Wozniak · 2024 to 2026
$2.2M
NIH HHS R01AI186380
6 · The paper itself

Abstract

Staphylococcus aureus is an opportunistic pathogen that forms robust biofilms. This poses several challenges to the host in successfully clearing the pathogen, thus leading to chronic infections. S. aureus biofilms combat neutrophils by releasing pore-forming toxins called leukocidins. This leads to the induction of neutrophil extracellular traps (NETs) and neutrophil death. NETs are primarily composed of host DNA laced with several potent antimicrobials, including histones. While NETs entrap microbes, the nuclease produced by S. aureus degrades NETs, potentially releasing NET-associated antimicrobials. It is still unknown how S. aureus can persist in a chronic infection despite the presence of several NET-associated antimicrobials. Our studies revealed that histone H3 is sequestered by S. aureus-derived extracellular DNA (eDNA) of the biofilm matrix. This resulted in the architectural modification of the biofilm due to the formation of eDNA-H3 aggregates and protection of S. aureus within the biofilm from the potential bactericidal effects of H3.

Indexed as

BiofilmsHistonesStaphylococcus aureusExtracellular TrapsExtrachromosomal DNAHumansNeutrophilsExtrachromosomal DNAHistones

Identifiers

PMID41974738
PMCPMC13254319

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.